Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp.

Microbes and Infection

Volumn 8, Issue 7, 2006, Pages 1967-1971

  Payot, Sophie ^a   Bolla, Jean Michel ^b   Corcoran, Deborah ^c   Fanning, Séamus ^c   Mégraud, Francis ^d   Zhang, Qijing ^e  

^a CEMAGREF   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d INSERM   (France)

^e IOWA STATE UNIVERSITY   (United States)

Author keywords

Antibiotic resistance mechanisms; Campylobacter; Efflux pumps; Fluoroquinolones; Macrolides

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; KETOLIDE; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; MOXIFLOXACIN; NAPHTHYL GROUP; PHENYLALANYLARGININE BETA NAPHTHYLAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CAMPYLOBACTER; GENE MUTATION; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MACROLIDES;

CAMPYLOBACTER;

EID: 33746631314     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.12.032     Document Type: Short Survey

References (43)

1. Friedman C.R., Neimann J., Wegener H.C., and Tauxe R.V. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nachamkin I., and Blaser M.J. (Eds). Campylobacter (2000), American Society for Microbiology, Washington 121-138
2. Moore J.E., Corcoran D., Dooley J.S.G., Fanning S., Lucey B., Matsuda M., McDowell D.A., Mégraud F., Millar B.C., O'Mahony R., O'Riordan L., O'Rourke M., Rao J.R., Rooney P.J., Sails A., and Whyte P. Campylobacter. Vet. Res. 36 (2005) 351-382
3. J.E. Moore, M.D. Barton, I.S. Blair, D. Corcoran, J.S.G Dooley, S. Fanning, I. Kempf, A.J. Lastovica, C.J. Lowery, M. Matsuda, D.A. McDowell, A. McMahon, B.C. Millar, J.R. Rao, P.J. Rooney, B.S. Seal, W.J. Snelling, O. Tolba, The epidemiology of antibiotic resistance in Campylobacter, Microb. Infect. in press.
4. Van Bambeke F., Michot J.M., Van Eldere J., and Tulkens P.M. Quinolones in 2005: an update. Clin. Microbiol. Infect. 11 (2005) 256-280
5. Jacoby G.A. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41 Suppl.2 (2005) S120-S126
6. Gibreel A., Sjogren E., Kaijser B., Wretlind B., and Skold O. Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrob. Agents Chemother. 42 (1998) 3276-3278
7. Fouts D.E., Mongodin E.F., Mandrell R.E., Miller W.G., Rasko D.A., Ravel J., Brinkac L.M., DeBoy R.T., Parker C.T., Daugherty S.C., Dodson R.J., Durkin A.S., Madupu R., Sullivan S.A., Shetty J.U., Ayodeji M.A., Shvartsbeyn A., Schatz M.C., Badger J.H., Fraser C.M., and Nelson K.E. Major structural differences and novel potential virulence mechanisms from the genomes of multiple Campylobacter species. PLoS Biol. 3 (2005) e15
8. Parkhill J., Wren B.W., Mungall K., Ketley J.M., Churcher C., Basham D., Chillingworth T., Davies R.M., Feltwell T., Holroyd S., Jagels K., Karlyshev A.V., Moule S., Pallen M.J., Penn C.W., Quail M.A., Rajandream M.A., Rutherford K.M., van Vliet A.H., Whitehead S., and Barrell B.G. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403 (2000) 665-668
9. Bachoual R., Ouabdesselam S., Mory F., Lascols C., Soussy C.J., and Tankovic J. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb. Drug Resist. 7 (2001) 257-261
10. Cooper R., Segal H., Lastovica A.J., and Elisha B.G. Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains. J. Appl. Microbiol. 93 (2002) 241-249
11. Payot S., Cloeckaert A., and Chaslus-Dancla E. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb. Drug Resist. 8 (2002) 335-343
12. Piddock L.J., Ricci V., Pumbwe L., Everett M.J., and Griggs D.J. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J. Antimicrob. Chemother. 51 (2003) 19-26
13. Luo N., Sahin O., Lin J., Michel L.O., and Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob. Agents Chemother. 47 (2003) 390-394
14. Wang Y., Huang W.M., and Taylor D.E. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 37 (1993) 457-463
15. Ruiz J., Moreno A., Jimenez de Anta M.T., and Vila J. A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates. Int. J. Antimicrob. Agents 25 (2005) 542-545
16. De E., Jullien M., Labesse G., Pages J.M., Molle G., and Bolla J.M. MOMP (major outer membrane protein) of Campylobacter jejuni; a versatile pore-forming protein. FEBS Lett. 469 (2000) 93-97
17. Bolla J.M., De E., Dorez A., and Pages J.M. Purification, characterization and sequence analysis of Omp50, a new porin isolated from Campylobacter jejuni. Biochem. J. 352 (2000) 637-643
18. Dedieu L., Pages J.M., and Bolla J.M. Use of the omp50 gene for identification of Campylobacter species by PCR. J. Clin. Microbiol. 42 (2004) 2301-2305
19. Pumbwe L., Randall L.P., Woodward M.J., and Piddock L.J. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J. Antimicrob. Chemother. 54 (2004) 341-347
20. Lin J., Michel L.O., and Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46 (2002) 2124-2131
21. Pumbwe L., and Piddock L.J. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol. Lett. 206 (2002) 185-189
22. Poole K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56 (2005) 20-51
23. Cagliero C., Mouline C., Payot S., and Cloeckaert A. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli. J. Antimicrob. Chemother. 56 (2005) 948-950
24. Corcoran D., Quinn T., Cotter L., O'Halloran F., and Fanning S. Characterisation of a cmeABC operon in a quinolone-resistant Campylobacter coli isolate of Irish origin. Microb. Drug Resist. 11 (2005) 303-308
25. Lin J., Sahin O., Michel L.O., and Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect. Immun. 71 (2003) 4250-4259
26. Lin J., Akiba M., and Zhang Q. Multidrug efflux systems in Campylobacter. In: Ketley J.M., and Konkel M.E. (Eds). Campylobacter: molecular and cellular biology (2005), Horizon Bioscience, Norfolk 205-218
27. Corcoran D., Quinn T., Cotter L., and Fanning S. Relative contribution of target gene mutation and efflux to varying quinolone resistance in Irish Campylobacter isolates. FEMS Microbiol. Lett. 253 (2005) 39-46
28. Pumbwe L., Randall L.P., Woodward M.J., and Piddock L.J. Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF. Antimicrob. Agents Chemother. 49 (2005) 1289-1293
29. Ge B., McDermott G., White D.G., and Meng J. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 49 (2005) 3347-3354
30. Franceschi F., Kanyo Z., Sherer E.C., and Sutcliffe J. Macrolide resistance from the ribosome perspective. Curr. Drug Targets Infect. Disord. 4 (2004) 177-191
31. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34 (2002) 482-492
32. Taylor D.E., and Tracz D.M. Mechanisms of antimicrobial resistance in Campylobacter. In: Ketley J.M., and Konkel M.E. (Eds). Campylobacter: molecular and cellular biology (2005), Horizon Bioscience, Norfolk 193-204
33. Roe D.E., Weinberg A., and Roberts M.C. Mobile rRNA methylase genes in Campylobacter (Wolinella) rectus. J. Antimicrob. Chemother. 36 (1995) 738-740
34. Vacher S., Menard A., Bernard E., and Megraud F. PCR-Restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. Antimicrob. Agents Chemother. 47 (2003) 1125-1128
35. Vacher S., Menard A., Bernard E., Santos A., and Megraud F. Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR. Microb. Drug Resist. 11 (2005) 40-47
36. Niwa H., Chuma T., Okamoto K., and Itoh K. Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay. Int. J. Antimicrob. Agents 18 (2001) 359-364
37. Payot S., Avrain L., Magras C., Praud K., Cloeckaert A., and Chaslus-Dancla E. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int. J. Antimicrob. Agents 23 (2004) 468-472
38. Jensen L.B., and Aarestrup F.M. Macrolide resistance in Campylobacter coli of animal origin in Denmark. Antimicrob. Agents Chemother. 45 (2001) 371-372
39. Gibreel A., Kos V.N., Keelan M., Trieber C.A., Levesque S., Michaud S., and Taylor D.E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49 (2005) 2753-2759
40. Corcoran D., Quinn T., Cotter L., and Fanning S. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int. J. Antimicrob. Agents 27 (2006) 40-45
41. Farrell D.J., Morrissey I., Bakker S., Buckridge S., and Felmingham D. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Antimicrob. Agents Chemother. 48 (2004) 3169-3171
42. Mamelli L., Prouzet-Mauléon V., Pages J.M., Mégraud F., and Bolla J.M. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J. Antimicrob. Chemother. 56 (2005) 491-497
43. Mamelli L., Amoros J.P., Pages J.M., and Bolla J.M. A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int. J. Antimicrob. Agents 22 (2003) 237-241